Found: 49
Select item for more details and to access through your institution.
Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-022-35716-1
- By:
- Publication type:
- Article
SOS Liver damage; calling all haematopoietic stem cells.
- Published in:
- Liver International, 2014, v. 34, n. 1, p. 1, doi. 10.1111/liv.12302
- By:
- Publication type:
- Article
Use of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet?
- Published in:
- Liver International, 2011, v. 31, n. 6, p. 775, doi. 10.1111/j.1478-3231.2011.02530.x
- By:
- Publication type:
- Article
Persistence of functional hepatocyte-like cells in immune-compromised mice.
- Published in:
- Liver International, 2011, v. 31, n. 2, p. 254, doi. 10.1111/j.1478-3231.2010.02414.x
- By:
- Publication type:
- Article
Bone marrow mesenchymal stem cells and liver regeneration: believe the hypoxia!
- Published in:
- Stem Cell Research & Therapy, 2013, v. 4, n. 5, p. 1, doi. 10.1186/scrt319
- By:
- Publication type:
- Article
Pretreatment of Mesenchymal Stem Cells Manipulates Their Vasculoprotective Potential While Not Altering Their Homing Within the Injured Gut.
- Published in:
- Stem Cells, 2015, v. 33, n. 9, p. 2785, doi. 10.1002/stem.2061
- By:
- Publication type:
- Article
The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation.
- Published in:
- PLoS Biology, 2018, v. 16, n. 9, p. 1, doi. 10.1371/journal.pbio.2005046
- By:
- Publication type:
- Article
The Role of a Dedicated Non-Alcoholic Fatty Liver Disease Clinic in 2016.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 4, p. 371, doi. 10.1159/000456589
- By:
- Publication type:
- Article
Bone Marrow Stem Cell Therapy for Liver Disease.
- Published in:
- Digestive Diseases, 2014, v. 32, n. 5, p. 494, doi. 10.1159/000360491
- By:
- Publication type:
- Article
A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42398-w
- By:
- Publication type:
- Article
Evaluation of the mechanisms of sarcopenia in chronic inflammatory disease: protocol for a prospective cohort study.
- Published in:
- Skeletal Muscle, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13395-021-00282-5
- By:
- Publication type:
- Article
A Switch in Hepatic Cortisol Metabolism across the Spectrum of Non Alcoholic Fatty Liver Disease.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0029531
- By:
- Publication type:
- Article
Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table.
- Published in:
- European Heart Journal, 2023, v. 44, n. 39, p. 4141, doi. 10.1093/eurheartj/ehad445
- By:
- Publication type:
- Article
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol.
- Published in:
- Systematic Reviews, 2016, v. 5, p. 1, doi. 10.1186/s13643-016-0277-6
- By:
- Publication type:
- Article
The Delivery of Multipotent Adult Progenitor Cells to Extended Criteria Human Donor Livers Using Normothermic Machine Perfusion.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01226
- By:
- Publication type:
- Article
Mesenchymal Stromal Cells, a New Player in Reducing Complications From Liver Transplantation?
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01306
- By:
- Publication type:
- Article
A Comparison of Phenotypic and Functional Properties of Mesenchymal Stromal Cells and Multipotent Adult Progenitor Cells.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01952
- By:
- Publication type:
- Article
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 15, p. 1287, doi. 10.1001/jama.2024.1447
- By:
- Publication type:
- Article
Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0241357
- By:
- Publication type:
- Article
Liver Disease and Cell Therapy: Advances Made and Remaining Challenges.
- Published in:
- Stem Cells, 2023, v. 41, n. 8, p. 739, doi. 10.1093/stmcls/sxad029
- By:
- Publication type:
- Article
PDGFRα/Sca-1 Sorted Mesenchymal Stromal Cells Reduce Liver Injury in Murine Models of Hepatic Ischemia-Reperfusion Injury.
- Published in:
- Stem Cells, 2022, v. 40, n. 11, p. 1056, doi. 10.1093/stmcls/sxac059
- By:
- Publication type:
- Article
Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.
- Published in:
- QJM: An International Journal of Medicine, 2017, v. 110, n. 2, p. 73, doi. 10.1093/qjmed/hcw151
- By:
- Publication type:
- Article
Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management.
- Published in:
- QJM: An International Journal of Medicine, 2014, v. 107, n. 1, p. 33, doi. 10.1093/qjmed/hct198
- By:
- Publication type:
- Article
Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1227, doi. 10.1111/liv.14825
- By:
- Publication type:
- Article
Non-alcoholic fatty liver disease: when to intervene and with what.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Non-alcoholic fatty liver disease: when to intervene and with what.
- Published in:
- Clinical Medicine, 2015, v. 15, n. 2, p. 186, doi. 10.7861/clinmedicine.15-2-186
- By:
- Publication type:
- Article
Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Mesenchymal stromal cells and liver fibrosis: a complicated relationship.
- Published in:
- FASEB Journal, 2016, v. 30, n. 12, p. 3905, doi. 10.1096/fj.201600433R
- By:
- Publication type:
- Article
Severe neurological crisis in adult patients with Tyrosinemia type 1.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 9, p. 1732, doi. 10.1002/acn3.51160
- By:
- Publication type:
- Article
Reply to: “From NAFLD to MASLD: Promise and pitfalls of a new definition’.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2024, v. 29, n. 4, p. 2, doi. 10.1016/j.aohep.2023.101178
- By:
- Publication type:
- Article
TGFβ<sub>1</sub> priming enhances CXCR3‐mediated mesenchymal stromal cell engraftment to the liver and enhances anti‐inflammatory efficacy.
- Published in:
- Journal of Cellular & Molecular Medicine, 2023, v. 27, n. 6, p. 864, doi. 10.1111/jcmm.17698
- By:
- Publication type:
- Article
Fat and Fibrosis: Does Empagliflozin Impair the Progression of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Hematopoietic stem cell trafficking in liver injury.
- Published in:
- FASEB Journal, 2005, v. 19, n. 10, p. 1225, doi. 10.1096/fj.04-2604rev
- By:
- Publication type:
- Article
Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial.
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-023-00634-3
- By:
- Publication type:
- Article
Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cellular therapies for the treatment of immune-mediated GI and liver disease.
- Published in:
- British Medical Bulletin, 2020, v. 136, n. 1, p. 127, doi. 10.1093/bmb/ldaa035
- By:
- Publication type:
- Article
Non-alcoholic fatty liver disease in 2016.
- Published in:
- British Medical Bulletin, 2016, v. 119, n. 1, p. 143, doi. 10.1093/bmb/ldw031
- By:
- Publication type:
- Article
3D human liver tissue from pluripotent stem cells displays stable phenotype in vitro and supports compromised liver function in vivo.
- Published in:
- Archives of Toxicology, 2018, v. 92, n. 10, p. 3117, doi. 10.1007/s00204-018-2280-2
- By:
- Publication type:
- Article
Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclature.
- Published in:
- Journal of Pediatric Gastroenterology & Nutrition, 2024, v. 78, n. 5, p. 1190, doi. 10.1002/jpn3.12156
- By:
- Publication type:
- Article
Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease.
- Published in:
- Stem Cell Research & Therapy, 2017, v. 8, p. 1, doi. 10.1186/s13287-017-0590-6
- By:
- Publication type:
- Article
Development of an invasively monitored porcinemodel of acetaminophen-induced acuteliver failure.
- Published in:
- BMC Gastroenterology, 2010, v. 10, p. 34, doi. 10.1186/1471-230X-10-34
- By:
- Publication type:
- Article
Optimising referral pathways for patients with non-alcoholic fatty liver disease in the UK.
- Published in:
- British Journal of Healthcare Management, 2021, v. 27, n. 3, p. 62, doi. 10.12968/bjhc.2020.0164
- By:
- Publication type:
- Article
Circulating myeloid populations have prognostic utility in alcohol-related liver disease.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1330536
- By:
- Publication type:
- Article
Editorial: re‐thinking cardiovascular risk factors in NAFLD with advanced fibrosis?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 10, p. 987, doi. 10.1111/apt.15682
- By:
- Publication type:
- Article
Commentary: advances in the pharmacotherapy of NASH—anti‐diabetic drugs and beyond.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 1, p. 199, doi. 10.1111/apt.15509
- By:
- Publication type:
- Article
Liver Transplantation From Donors With Acute Intermittent Porphyria.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Patient and public perspectives on cell and gene therapies: a systematic review.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-20096-1
- By:
- Publication type:
- Article
NAFLD Is Underrecognized in The Primary Care Setting: UK Experience.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2014, v. 109, n. 9, p. 1500, doi. 10.1038/ajg.2014.207
- By:
- Publication type:
- Article